참고문헌
- Vance DJ, Mantis NJ., "Progress and challenges associated with the development of ricin toxin subunit vaccines," Expert Rev Vaccines., Sep;15(9), pp. 1213-1222, 2016. https://doi.org/10.1586/14760584.2016.1168701
- Endo Y, Tsurugi K., "RNA N-glycosidase activity of ricin A-chain. Mechanism of action of the toxic lectin ricin on eukaryotic ribosomes," J Biol Chem, Jun 15;262(17), pp. 8128-8130, 1987. https://doi.org/10.1016/S0021-9258(18)47538-2
- Magnusson S, Kjeken R, Berg T., "Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells," Exp Cell Res, Mar;205(1), pp. 118-125, 1993. https://doi.org/10.1006/excr.1993.1065
- Smallshaw JE, Richardson JA, Pincus S, Schindler J, Vitetta ES., "Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin," Vaccine, Sep 15;23(39), pp. 4775-4784, 2005. https://doi.org/10.1016/j.vaccine.2005.04.037
- Griffiths GD, Phillips GJ, Holley J., "Inhalation toxicology of ricin preparations: animal models, prophylactic and therapeutic approaches to protection," Inhal Toxicol, Aug;19(10), pp. 873-887, 2007. https://doi.org/10.1080/08958370701432124
- Baluna R, Rizo J, Gordon BE, Ghetie V, Vitetta ES., "Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome," Proc Natl Acad Sci U S A., Mar 30;96(7), pp. 3957-3962, 1999. https://doi.org/10.1073/pnas.96.7.3957
- Griffiths GD, Phillips GJ, Bailey SC., "Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation," Vaccine, Jun 4;17(20-21), pp. 2562-2568. 1999. https://doi.org/10.1016/S0264-410X(99)00054-7
- Smallshaw JE, Firan A, Fulmer JR, Ruback SL, Ghetie V, Vitetta ES., "A novel recombinant vaccine which protects mice against ricin intoxication," Vaccine, Sep 10;20(27-28), pp. 3422-3427, 2002. https://doi.org/10.1016/S0264-410X(02)00312-2
- Olson MA, Carra JH, Roxas-Duncan V, Wannemacher RW, Smith LA, Millard CB., "Finding a new vaccine in the ricin protein fold," Protein Eng Des Sel, Apr;17(4), pp. 391-397, 2004. https://doi.org/10.1093/protein/gzh043
- Smallshaw JE, Richardson JA, Pincus S, Schindler J, Vitetta ES., "Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin," Vaccine, Sep 15;23(39), pp. 4775-4784, 2005. https://doi.org/10.1016/j.vaccine.2005.04.037
- Carra JH, Wannemacher RW, Tammariello RF, Lindsey CY, Dinterman RE, Schokman RD, Smith LA., "Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity," Vaccine, May 22;25(21), pp. 4149-4158, 2007. https://doi.org/10.1016/j.vaccine.2007.03.011
- De Gregorio E, D'Oro U, Wack A., "Immunology of TLR-independent vaccine adjuvants," Curr Opin Immunol, Jun;21(3), pp. 339-345, 2009. https://doi.org/10.1016/j.coi.2009.05.003
- Steinhagen F, Kinjo T, Bode C, Klinman DM., "TLR-based immune adjuvants," Vaccine, Apr 12;29(17), pp. 3341-3355, 2011. https://doi.org/10.1016/j.vaccine.2010.08.002
- Apostolico Jde S, Lunardelli VA, Coirada FC, Boscardin SB, Rosa DS., "Adjuvants: Classification, Modus Operandi, and Licensing," J Immunol Res., pp. 14593-14594, 2016.
- Hutchison S, Benson RA, Gibson VB, Pollock AH, Garside P, Brewer JM., "Antigen depot is not required for alum adjuvanticity," FASEB J, Mar;26(3), pp. 1272-1279, 2012. https://doi.org/10.1096/fj.11-184556
- Delneste Y, Beauvillain C, Jeannin P., "Immunite naturelle: structure et fonction des Toll-like receptors [Innate immunity: structure and function of TLRs]," Med Sci (Paris), Jan;23(1), pp. 67-73, 2007. https://doi.org/10.1051/medsci/200723167
- Akira S, Uematsu S, Takeuchi O., "Pathogen recognition and innate immunity," Cell, Feb 24;124(4), pp. 783-801, 2006. https://doi.org/10.1016/j.cell.2006.02.015
- Qureshi N, Mascagni P, Ribi E, Takayama K., "Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination," J Biol Chem, May 10;260(9), pp. 5271-5278, 1985. https://doi.org/10.1016/S0021-9258(18)89017-2
- Mazzeo S, Cappelli C, Caramella D, Belcari A, Forasassi F, Battaglia V, Giannini A, Pasquariello R, Pallocci S, Caproni G, Marcocci C, Pinchera A, Miccoli P, Bartolozzi C., "Multidetector CT in diagnostic work-up of patients with primary hyperparathyroidism," Radiol Med, Aug;112(5), pp. 763-775, 2007. https://doi.org/10.1007/s11547-007-0179-8
- Gorden KB, Gorski KS, Gibson SJ, Kedl RM, Kieper WC, Qiu X, Tomai MA, Alkan SS, Vasilakos JP., "Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8," J Immunol, Feb 1;174(3), pp. 1259-1268, 2005. https://doi.org/10.4049/jimmunol.174.3.1259
- Wagner H., "Bacterial CpG DNA activates immune cells to signal infectious danger," Adv Immunol., 73, pp. 329-368, 1999. https://doi.org/10.1016/S0065-2776(08)60790-7
- Olson MA., "Ricin A-chain structural determinant for binding substrate analogues: a molecular dynamics simulation analysis, Proteins, Jan;27(1), pp. 80-95, 1997. https://doi.org/10.1002/(SICI)1097-0134(199701)27:1<80::AID-PROT9>3.0.CO;2-R
- Armitage P, Allen I., "Methods of estimating the LD 50 in quantal response data," J Hyg(Lond), Sep;48(3), pp. 298-322, 1950. https://doi.org/10.1017/S0022172400015084